Blackrock Health Sciences Trust Bearish Trade. Bank Of America Corp decreased Its Position

Bank Of America Corp Reported reduced Interest in Blackrock Health Sciences Trust

Bank Of America Corp filed with SEC a SC 13G/A form about Blackrock Health Sciences Trust. The form can be accessed here: 000114036116053084. As reported by Bank Of America Corp , the filler decreased its stake in the stock by -6.72% for 846,635 shares. Bank Of America Corp currently owns 10.44% of the Health Care- stock. This ownership filing was filed because activity on December31,2015.

Blackrock Health Sciences Trust Institutional Sentiment

Latest Security and Exchange filings show 22 investors own Blackrock Health Sciences Trust. The institutional ownership in Q3 2015 is low, at 15.93% of the outstanding shares. This is decreased by 36869 the total institutional shares. 1252042 were the shares owned by these institutional investors. In total 4 funds opened new Blackrock Health Sciences Trust stakes, 5 increased stakes. There were 5 that closed positions and 6 reduced them.

National Planning Corp is an institutional investor bullish on Blackrock Health Sciences Trust, owning 12625 shares as of Q3 2015 for 0.05% of its portfolio. 1St Source Bank owns 7359 shares or 0.03% of its portfolio. TX Doliver Capital Advisors Inc have 0.25% of their stock portfolio for 8888 shares. Further, Cordasco Financial Network reported stake worth 0.02% of its US stock portfolio. The MD Financial Advantage Inc owns 749 shares. Blackrock Health Sciences Trust is 0.03% of the manager’s US portfolio.

Business Profile

BlackRock Health Sciences Trust’s (BME) (the Trust) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield. The Trust invests in sectors, such as Pharmaceuticals, Biotechnology, Health Care Equipment & Supplies., Health Care Providers & Services and Life Sciences Tools & Services. The Fund’s investment advisor is BlackRock Advisors, LLC.

SEC Form 13G is required when the filer owns between (5% and 20%) of a company and plans to hold it only as a passive investor. In case the filler intend to exert control and the stake’s exceeds 20%, then 13D Form must be filed. These filings can NOT be a precursor to “change of control” events such as hostile takeovers, company breakups or others.

The institutional sentiment increased to 0.82 in Q3 2015. Its up 0.07, from 0.75 in 2015Q2. The ratio increased, as 5 funds sold all Blackrock Health Sciences Trust shares owned while 6 reduced positions. 4 funds bought stakes while 5 increased positions. They now own 1.25 million shares or 2.86% less from 1.29 million shares in 2015Q2.

Doliver Capital Advisors Inc. holds 0.25% of its portfolio in Blackrock Health Sciences Trust for 8,888 shares. National Planning Corp owns 12,625 shares or 0.05% of their US portfolio. Moreover, Clenar Muke Llc has 0.04% invested in the company for 15,069 shares. The Indiana-based 1St Source Bank has invested 0.03% in the stock. Financial Advantage Inc., a Maryland-based fund reported 749 shares.

The stock decreased 2.21% or $0.76 on February 18, hitting $33.45. Blackrock Health Sciences Trust (NYSE:BME) has declined 25.77% since July 15, 2015 and is downtrending. It has underperformed by 16.77% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Add Comment